07:00 , Aug 22, 2016 |  BC Week In Review  |  Company News

Rasna, Active With Me deal

Rasna reverse-merged with Active With Me. The combined company retained Rasna’s name and will focus on modulating nucleophosmin ( NPM1; B23) and lysine-specific demethylase 1 ( LSD1; KDM1A), which it says is...
07:00 , May 19, 2014 |  BioCentury  |  Finance

Highlights of weekly biotech stock moves

Regulatory milestones Kythera Biopharmaceuticals Inc. (NASDAQ:KYTH) gained $1.85 to $33.22 last week after submitting an NDA to FDA for deoxycholic acid (ATX-101) to reduce submental (under chin) fat. Kythera plans to submit ex-U.S. regulatory applications by...
07:00 , May 5, 2014 |  BioCentury  |  Finance

Highlights of weekly biotech stock moves

Regulatory milestones Acorda Therapeutics Inc. (NASDAQ:ACOR) fell $3.51 (10%) to $32.39 on Friday after FDA asked for an additional clinical trial in a complete response letter for Plumiaz diazepam nasal spray to treat acute repetitive seizures...
07:00 , Apr 7, 2014 |  BioCentury  |  Finance

Highlights of weekly biotech stock moves

Regulatory milestones Cubist Pharmaceuticals Inc. (NASDAQ:CBST) was off $1.66 to $68.44 last week after FDA's Anti-Infective Drugs Advisory Committee voted unanimously in favor of approval of Sivextro tedizolid to treat acute bacterial skin and skin structure...
07:00 , Mar 10, 2014 |  BioCentury  |  Analyst Picks & Changes

Analyst picks & changes

Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 3/7 cls Biogen Idec Inc. (NASDAQ:BIIB) BMO Capital Markets Jim Birchenough Upgrade Outperform...
08:00 , Nov 25, 2013 |  BioCentury  |  Analyst Picks & Changes

Analyst picks & changes

Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 11/22 cls Aerie Pharmaceuticals Inc. (NASDAQ:AERI) Canaccord Ritu Baral New Buy 9%...
08:00 , Nov 18, 2013 |  BioCentury  |  Finance

Highlights of weekly biotech stock moves

Regulatory milestones Algeta ASA (OSE:ALGETA) was off NOK4.60 to NOK263.40 on Friday after the European Commission approved an MAA from partner Bayer AG (Xetra:BAYN) for Xofigo radium-223 dichloride to treat adults with castration-resistant prostate cancer (CRPC),...
07:00 , Oct 28, 2013 |  BioCentury  |  Finance

Highlights of weekly biotech stock moves

Regulatory milestones Actelion Ltd. (SIX:ATLN) was off CHF0.20 to CHF69.15 on Friday after EMA's CHMP backed approval of Opsumit macitentan for pulmonary arterial hypertension (PAH). Actelion gained CHF4.55 on the week. The move included a bump from...
07:00 , Oct 14, 2013 |  BioCentury  |  Analyst Picks & Changes

Analyst picks & changes

Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 10/11 cls Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) Barclays Capital Ying Huang Downgrade Underweight (from...
07:00 , Oct 7, 2013 |  BioCentury  |  Finance

Regulatory milestones

Regulatory milestones AcelRx Pharmaceuticals Inc. (NASDAQ:ACRX) gained $0.37 to $10.96 last week after submitting an NDA to FDA for Zalviso sufentanil sublingual microtablet system to manage moderate to severe acute pain in a hospital setting. The...